Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-07-12

Clinical Trial Update: FSH Receptor Polymorphism p.N680S and Efficacy of FSH Therapy [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/3 trial examined whether the FSH receptor p.N680S polymorphism influences the effectiveness of follicle-stimulating hormone therapy in men w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Follicle-stimulating hormone (FSH) (Follicle-stimulating hormone)

Snippet

Sponsor: Azienda USL Modena | Conditions: Male Infertility | Phase 2, Phase 3 | Status: COMPLETED